Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guidelines for the use of biochemical markers of bone turnover in osteoporosis (2004).
Nishizawa Y, Nakamura T, Ohta H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Chaki O, Ichimura S, Nakatsuka K, Miura M; Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis Japan Osteoporosis Society. Nishizawa Y, et al. Among authors: gorai i. J Bone Miner Metab. 2005;23(2):97-104. doi: 10.1007/s00774-004-0547-6. J Bone Miner Metab. 2005. PMID: 15750686 No abstract available.
Diagnostic criteria for primary osteoporosis: year 2012 revision.
Soen S, Fukunaga M, Sugimoto T, Sone T, Fujiwara S, Endo N, Gorai I, Shiraki M, Hagino H, Hosoi T, Ohta H, Yoneda T, Tomomitsu T; Japanese Society for Bone and Mineral Research and Japan Osteoporosis Society Joint Review Committee for the Revision of the Diagnostic Criteria for Primary Osteoporosis. Soen S, et al. Among authors: gorai i. J Bone Miner Metab. 2013 May;31(3):247-57. doi: 10.1007/s00774-013-0447-8. Epub 2013 Apr 4. J Bone Miner Metab. 2013. PMID: 23553500
Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001).
Nishizawa Y, Nakamura T, Ohata H, Kushida K, Gorai I, Shiraki M, Fukunaga M, Hosoi T, Miki T, Nakatsuka K, Miura M; Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis: Japan Osteoporosis Society. Nishizawa Y, et al. Among authors: gorai i. J Bone Miner Metab. 2001;19(6):338-44. doi: 10.1007/s007740170002. J Bone Miner Metab. 2001. PMID: 11685648 No abstract available.
Validation of the Japanese Osteoporosis Quality of Life Questionnaire.
Kumamoto K, Nakamura T, Suzuki T, Gorai I, Fujinawa O, Ohta H, Shiraki M, Yoh K, Fujiwara S, Endo N, Matsumoto T. Kumamoto K, et al. Among authors: gorai i. J Bone Miner Metab. 2010;28(1):1-7. doi: 10.1007/s00774-009-0125-z. J Bone Miner Metab. 2010. PMID: 19826753
Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures: rationale, aims and organization of a Japanese Osteoporosis Intervention Trial (JOINT) initiated by the Research Group of Adequate Treatment of Osteoporosis (A-TOP).
Shiraki M, Kuroda T, Miyakawa N, Fujinawa N, Tanzawa K, Ishizuka A, Tanaka S, Tanaka Y, Hosoi T, Itoi E, Morimoto S, Itabashi A, Sugimoto T, Yamashita T, Gorai I, Mori S, Kishimoto H, Mizunuma H, Endo N, Nishizawa Y, Takaoka K, Ohashi Y, Ohta H, Fukunaga M, Nakamura T, Orimo H. Shiraki M, et al. Among authors: gorai i. J Bone Miner Metab. 2011 Jan;29(1):37-43. doi: 10.1007/s00774-010-0188-x. Epub 2010 May 13. J Bone Miner Metab. 2011. PMID: 20461422 Clinical Trial.
Comparison of concurrent treatment with vitamin K2 and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.
Tanaka S, Miyazaki T, Uemura Y, Miyakawa N, Gorai I, Nakamura T, Fukunaga M, Ohashi Y, Ohta H, Mori S, Hagino H, Hosoi T, Sugimoto T, Itoi E, Orimo H, Shiraki M. Tanaka S, et al. Among authors: gorai i. J Bone Miner Metab. 2017 Jul;35(4):385-395. doi: 10.1007/s00774-016-0768-5. Epub 2016 Aug 2. J Bone Miner Metab. 2017. PMID: 27484436 Clinical Trial.
68 results